Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Concordance analysis between liquid biopsy (ctDNA) and tumor DNA molecular profiles from panel-based next-generation sequencing.

Authors:
Natalia Rodon Font Yessica No Garbarino Olga Díaz Castello Juan Moya Amoros Pedro Barrios Sánchez David Coroleu Lletget Mª Antonia Lequerica Cabello Joan Borras Marcet Sandra Mecho Meca Isabel Escape Javier Martinez-Agea Estefania Garcia Marta Ferrer Xavier Puig Torrus

Rev Esp Patol 2022 Jul-Sep;55(3):156-162. Epub 2022 Apr 25.

BIOPAT, Biopatologia Molecular SL, Grup Assistència, Avenida Diagonal, 660, 08034, Barcelona, Spain; Histopat Laboratoris SL, Calle Mendel, 1, 08034, Barcelona, Spain; SCIAS-Hospital de Barcelona, Grup Assistència, Avenida Diagonal, 660, 08034, Bracelona, Spain.

Introduction: Analysis of circulating tumor DNA (ctDNA), also known as liquid biopsy, has been postulated to be a useful test in the prognostication, molecular profiling, and monitoring of cancer patients. In this series we aimed to analyze the concordance between the mutation status of formalin-fixed paraffin-embedded (FFPE) tumor samples and matched ctDNA, considering tumor molecular profiling as the gold standard technique.

Methods: This retrospective study included cancer patients with complete diagnostics and gene mutations detected in a previous FFPE tumor tissue Next-Generation Sequencing (NGS) study with a matched frozen plasma sample available for an NGS ctDNA assay.

Results And Discussion: Sixty patients were included, 24 with colorectal carcinoma (CRC) and 36 with non-small cell lung cancer (NSCLC). In 27.1% of ctDNA studies a new mutation not previously detected in the matched tumor was found. 11.9% of these ctDNA results had the potential to impact clinical management. Globally, the concordance rate between FFPE tumor samples and ctDNA was 44.4%. When tumors were stratified by stage, the concordance was 76.5%, 70%, 36.4%, and 0% in tumor stages IV, III, II, and I, respectively. ctDNA molecular profiles showed a good concordance rate in advanced stage tumors and identified undetected mutations in tumor tissues. In early tumor stages the concordance was low, casting doubt on the usefulness of ctDNA in these patients.

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.patol.2022.01.001DOI Listing
July 2022

Publication Analysis

Top Keywords

ffpe tumor
12
tumor
10
ctdna
9
molecular profiling
8
tumor stages
8
tumor samples
8
cancer patients
8
liquid biopsy
8
next-generation sequencing
8
molecular profiles
8
concordance rate
8
tumor dna
8
concordance
6
271% ctdna
4
nsclc 271%
4
ctdna studies
4
cancer nsclc
4
lung cancer
4
cell lung
4
non-small cell
4

Keyword Occurance

Similar Publications

Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma.

Authors:
Juliane Lippert Barbara Altieri Breanna Morrison Sonja Steinhauer Gabrielle Smith Antonia Lorey Hanna Urlaub Stefan Kircher Alice Sitch Martin Fassnacht Cristina L Ronchi

J Clin Endocrinol Metab 2022 Aug 5. Epub 2022 Aug 5.

Division of Endocrinology and Diabetes, University Hospital of Wuerzburg , Germany.

Context: Adrenocortical carcinoma (ACC) is a rare aggressive disease with heterogeneous prognosis. Previous studies identified hypermethylation in the promoter region of specific genes to be associated with poor clinical outcome.

Objective: Comparative analysis of promising hypermethylated genes as prognostic markers and evaluation of their added value to established clinical prognostic tools. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.

Authors:
Hyojin Kim Shin Eun Woo-Jin Jeong Soon-Hyun Ahn Yun Jung Bae Joong Seob Lee Heejin Kim

Sci Rep 2022 Aug 4;12(1):13383. Epub 2022 Aug 4.

Department of Otorhinolaryngology-Head and Neck Surgery, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.

Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignancy that transforms from PA. Early detection of the carcinoma by biopsy is difficult due to similar histopathology of the malignant and benign components. To address this, we investigated and compared the characteristic miRNA expression patterns across samples of the PA, carcinomatous portions (CA) of CXPA, as well as conventional PA. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Proteotypic Differences of Follicular-Patterned Thyroid Neoplasms.

Authors:
Dongdong Huang Huifang Zhang Lu Li Weigang Ge Wei Liu Zhen Dong Jinlong Gao Nan Yao Wenxin Fu Lingling Huang Tiannan Guo Yaoting Sun Xiaodong Teng

Front Endocrinol (Lausanne) 2022 6;13:854611. Epub 2022 Jul 6.

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

The diagnosis of follicular-patterned thyroid tumors such as follicular thyroid adenoma (FA), follicular thyroid carcinoma (FTC), and follicular variant of papillary thyroid carcinoma (FvPTC) remains challenging. This study aimed to explore the molecular differences among these three thyroid tumors by proteomic analysis. A pressure cycling technology (PCT)-data-independent acquisition (DIA) mass spectrometry workflow was employed to investigate protein alterations in 52 formalin-fixed paraffin-embedded (FFPE) specimens: 18 FA, 15 FTC, and 19 FvPTC specimens. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Identification of a Rare Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report.

Authors:
YunYu Lin Yan Lei LinWei Li Xiaoxing Su Qiqi Tian Wendy Wu

Onco Targets Ther 2022 28;15:831-836. Epub 2022 Jul 28.

Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China.

Objective: Previous studies have shown that fusion partners have a potential role in influencing different tumorigenic abilities of ROS1 fusion variants, as well as potential differential responses to crizotinib. Therefore, it is important to accurately identify the type of ROS1 rearrangement in NSCLC for clinical treatment selection.

Materials And Methods: Deep-coverage targeting solid tumor 31 cancer-related genes panel was used to capture DNA-based NGS information to detect gene fusion. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Predictive value of KRAS/NRAS, IL-4 VNTR and HPV alterations in metastases of colorectal cancer.

Authors:
Filiz Ozen Zeynep Yegin Cumhur Avsar Tulay Zenginkinet Haydar Koc Celal Ulasoglu

Bratisl Lek Listy 2022 Aug 1. Epub 2022 Aug 1.

Purpose: The main aim of the study was to evaluate the potential roles of KRAS/NRAS proto-oncogenes, IL-4 VNTR variants and HPV prevalence in colorectal cancer metastasis. As the second aim, the interactions of the analyzed genes and viral sequences with both clinicopathological variables and each other were targeted.

Methods: DNA was extracted using AmoyDx FFPE DNA Extraction kit from paraffin-embedded colorectal tumor tissue samples (n = 60). Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}